We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

HP Accelerates Life-saving Research with InkJet Technology

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

HP has introduced an innovative new HP InkJet-based dispensing instrument that enables pharmaceutical and life science researchers to help increase lab productivity through faster, more precise dispensing of very small volumes of chemical compounds and biomolecules.

Building on the HP D300 Digital Dispenser, the HP D300e Digital Dispenser broadens testing capabilities, enabling dispensing in aqueous-based solutions in addition to solvent. HP D300e software simplifies complex experimental layouts, such as those required for drug synergy studies, and features digital randomization to help researchers design experiments that maximize results.

HP digital InkJet dispensing technology is already in use by pharmaceutical and life science institutions for evaluating potential drug compounds’ effectiveness to treat diseases, such as cancer, AIDS and sickle cell anemia. Harvard Medical School’s Department of Systems Biology is using the HP D300e Digital Dispenser to help measure the response of cancer cell lines to therapeutic drugs and soluble components of the tumor micro-environment.

“In my research, I need to dispense drugs in solvent and peptides in aqueous solutions across large concentration ranges to analyze the effects on cancer cells,” said Dr. Mario Niepel, Ph.D., instructor, Laboratory of Systems Pharmacology and Department of Systems Biology, Harvard Medical School. “The HP D300e Digital Dispenser saves time and energy in the lab, enabling me to digitally randomize treatments and easily design and execute complicated drug combination experiments that would otherwise be too difficult to do.”

The new HP D300e Digital Dispenser enables researchers to eliminate several error-prone, time consuming and arduous steps - often done by hand pipetting or with expensive robotic systems - required to experiment with small volumes of valuable fluids.

“Accurate research and timely drug discovery is critical to addressing health and wellness challenges faced across the world,” said Annette Friskopp, vice president and general manager, Specialty Printing Systems, HP. “The HP D300e Digital Dispenser will increase experimental accuracy, testing reproducibility and overall laboratory efficiency, expediting scientific advancements.”